Clostridium Chauvoei + Clostridium Novyi + Clostridium Perfringens Type C Bacterin Toxoid + Clostridium Perfringens Type D Bacterin Toxoid + Clostridium Septicum + Clostridium Sordellii + Haemophilus Somnus Bacterin Toxoid
17 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
17
Total Reports
15
Deaths Reported
8820.0%
Death Rate
Active Ingredients
Clostridium ChauvoeiClostridium NovyiClostridium Perfringens Type C Bacterin ToxoidClostridium Perfringens Type D Bacterin ToxoidClostridium SepticumClostridium SordelliiHaemophilus Somnus Bacterin Toxoid
Administration Routes
SubcutaneousUnknown
Species Affected
Cattle 17
Most Affected Breeds
Cattle (other) 10
Aberdeen Angus 5
Crossbred Bovine/Cattle 1
Cattle (unknown) 1
Most Reported Reactions
Death 14
Lack of efficacy - NOS 8
Lack of efficacy (bacteria) - NOS 4
Necropsy performed 3
Lethargy (see also Central nervous system depression in 'Neurological') 2
Open mouth breathing 1
Depression 1
Panting 1
Recumbency 1
Foam in the nose 1
NT - Abnormal necropsy finding NOS 1
Lack of efficacy (bacteria NOS) 1
Outcome Breakdown
Died
15 (44.1%)
Recovered/Normal
11 (32.4%)
Outcome Unknown
5 (14.7%)
Ongoing
2 (5.9%)
Recovered with Sequela
1 (2.9%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.